Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Neurochemical Transmission: Sites of Drug Action01:26

Neurochemical Transmission: Sites of Drug Action

2.2K
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
2.2K
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

1.3K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.3K
Toxic Reactions: Overview01:26

Toxic Reactions: Overview

958
When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
958
Neuroplasticity01:01

Neuroplasticity

314
Neuroplasticity reflects the brain's remarkable capacity to adapt and evolve, responding dynamically to learning, experiences, or injury by reorganizing its neural circuitry. This reorganization involves creating new neural connections and refining old ones through a series of biological processes that contribute to the brain's lifelong development and adaptability.
314
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin01:26

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin

661
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
661

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Treatment Satisfaction, Improvements in Jawline Definition, and Psychosocial Impact With OnabotulinumtoxinA for Platysma Prominence: Patient-Reported Outcomes From 2 Multicenter, Randomized, Placebo-Controlled Phase 3 Studies.

Aesthetic surgery journal·2026
Same author

Acquired Blepharoptosis for the Dermatologic Surgeon: Recognition, Assessment, and Nonsurgical Management.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]·2026
Same author

Time Well Spent! Longer Initial Cosmetic Consultations Associated With Higher Same-Day Treatment and Patient Retention.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]·2026
Same author

Weight Loss and Its Impact on Soft Tissue.

Journal of drugs in dermatology : JDD·2026
Same author

Proof of Concept, Feasibility, and Safety of Local Anticholinesterase Treatment for Neuromodulator-Induced Facial Muscle Paralysis.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]·2026
Same author

Skincare Regimens for Men: Medical-Grade Solutions.

Facial plastic surgery : FPS·2025
Same journal

Punch Debridement as an Alternative Minimally Invasive Technique in the Management of Hidradenitis Suppurativa: A Single-center Study.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]·2026
Same journal

Evaluation of Lentigo Maligna With Additional Immunohistochemical Staining on Frozen Sections With PRAME, Melan-A, and SOX10.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]·2026
Same journal

A Comprehensive Review of Dermal Fillers and Biostimulators for Neck Rejuvenation.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]·2026
Same journal

Reconstruction of a Defect Involving the Upper Lip, Alar Base, and Medial Cheek.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]·2026
Same journal

Extramammary Paget Disease: A Single-Center, Clinical Analysis.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]·2026
Same journal

Frozen Section Biopsy as a Real-Time Decision-Support Tool in Dermatologic Surgery: A Retrospective Review.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]·2026
See all related articles

Related Experiment Video

Updated: Jun 15, 2025

Functional Evaluation of Biological Neurotoxins in Networked Cultures of Stem Cell-derived Central Nervous System Neurons
15:05

Functional Evaluation of Biological Neurotoxins in Networked Cultures of Stem Cell-derived Central Nervous System Neurons

Published on: February 5, 2015

9.3K

New and Future Developments in Neurotoxins.

Steve Yoelin1, Deirdre Hooper2

  • 1Medical Associates, Inc., Newport Beach, California.

Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|August 28, 2024
PubMed
Summary
This summary is machine-generated.

New botulinum neurotoxin research explores faster-acting type E toxins and novel therapeutic uses. Developments aim to address challenges like treatment frequency and lack of reversal agents for enhanced outcomes.

More Related Videos

A High Content Imaging Assay for Identification of Botulinum Neurotoxin Inhibitors
14:10

A High Content Imaging Assay for Identification of Botulinum Neurotoxin Inhibitors

Published on: November 14, 2014

8.6K
A High-throughput-compatible FRET-based Platform for Identification and Characterization of Botulinum Neurotoxin Light Chain Modulators
10:30

A High-throughput-compatible FRET-based Platform for Identification and Characterization of Botulinum Neurotoxin Light Chain Modulators

Published on: December 27, 2013

5.3K

Related Experiment Videos

Last Updated: Jun 15, 2025

Functional Evaluation of Biological Neurotoxins in Networked Cultures of Stem Cell-derived Central Nervous System Neurons
15:05

Functional Evaluation of Biological Neurotoxins in Networked Cultures of Stem Cell-derived Central Nervous System Neurons

Published on: February 5, 2015

9.3K
A High Content Imaging Assay for Identification of Botulinum Neurotoxin Inhibitors
14:10

A High Content Imaging Assay for Identification of Botulinum Neurotoxin Inhibitors

Published on: November 14, 2014

8.6K
A High-throughput-compatible FRET-based Platform for Identification and Characterization of Botulinum Neurotoxin Light Chain Modulators
10:30

A High-throughput-compatible FRET-based Platform for Identification and Characterization of Botulinum Neurotoxin Light Chain Modulators

Published on: December 27, 2013

5.3K

Area of Science:

  • Neurology
  • Dermatology
  • Pharmacology

Background:

  • Seven botulinum neurotoxin serotypes (A-G) are known, with A and B currently commercialized.
  • This review focuses on emerging neurotoxins and their evolving clinical applications.
  • The field is advancing beyond current limitations of treatment duration and reversal agents.

Purpose of the Study:

  • To offer insights into novel botulinum neurotoxins.
  • To explore emerging therapeutic modalities and clinical applications.
  • To discuss advancements in modulating neurotoxin effects.

Main Methods:

  • Literature review of relevant scientific publications.
  • Expert opinion and analysis of future trends in neurotoxin research.
  • Discussion of potential clinical applications based on current research.

Main Results:

  • Botulinum neurotoxin type E offers faster onset and shorter duration, differentiating it for specific uses.
  • Development is progressing for type E in aesthetic and therapeutic applications requiring rapid, short-lived effects.
  • New agents are being developed to overcome challenges like frequent treatments and lack of reversal agents.

Conclusions:

  • Botulinum neurotoxin type E's unique profile makes it suitable for applications demanding quick onset and short duration.
  • Future research and development will focus on addressing limitations of current neuromodulators.
  • Novel indications, including melanogenesis inhibition, are under investigation for botulinum neurotoxins.